Stock IRWD IRONWOOD PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Ironwood Pharmaceuticals, Inc.

Equities

IRWD

US46333X1081

Real-time Estimate Cboe BZX
Other stock markets
 14:46:54 2024-05-07 EDT 		5-day change 1st Jan Change
8.095 USD -0.18% Intraday chart for Ironwood Pharmaceuticals, Inc. +4.19% -29.41%
03-28 Ironwood Pharmaceuticals, Inc. Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD) CI
02-29 Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Piper Sandler Adjusts Price Target on Ironwood Pharmaceuticals to $21 From $20, Maintains Overweight Rating
MT
Craig-Hallum Starts Coverage on Ironwood Pharmaceuticals with Buy Rating, $21 Price Target
MT
JMP Securities Starts Ironwood Pharmaceuticals at Market Outperform, $22 Price Target
MT
Piper Sandler Adjusts Price Target on Ironwood Pharmaceuticals to $19 From $16, Maintains Overweight Rating
MT
Capital One Securities Initiates IRWD at Overweight with $15 Price Target
MT
Wells Fargo Adjusts Ironwood Pharmaceuticals' Price Target to $13 from $12, Maintains Equalweight Rating
MT
Piper Sandler Starts Ironwood Pharmaceuticals at Overweight With $16 Price Target
MT
IRONWOOD PHARMACEUTICALS : Morgan Stanley Adjusts Price Target on Ironwood Pharmaceuticals to $14 From $13, Maintains Equal-Weight Rating
MT
IRONWOOD PHARMACEUTICALS : Morgan Stanley Adjusts Price Target on Ironwood Pharmaceuticals to $12 From $11, Maintains Equal-Weight Rating
MT
IRONWOOD PHARMACEUTICALS : Morgan Stanley Adjusts Ironwood Pharmaceuticals' Price Target to $12 from $11, Keeps Equalweight Rating
MT
IRONWOOD PHARMACEUTICALS : Credit Suisse Adjusts Ironwood Pharmaceuticals' Price Target to $12 From $11, Maintains Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IRWD Stock
  4. News Ironwood Pharmaceuticals, Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW